![Hong Bin Dai](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 14 M $ al 31/05/2026
Hong Bin Dai has been Vice Chairman at Jiangsu Hengrui Pharmaceuticals Co., Ltd. since 2025.
Education history includes a graduate degree from Wuhan University conferred in 2011 and a graduate degree from Zhongnan University of Economics & Law conferred in 2000.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 25/03/2026 | 1.888.842 ( 0,03 % ) | 14 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD | Director/Miembro de la Junta | 16/01/2020 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Wuhan University
 Wuhan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products for treatment of cancer | Health Technology |
Zhongnan University of Economics & Law
 Zhongnan University of Economics & Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
Elige MarketScreener 
